This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
In this fireside chat webinar, experts break down the FDA's new PDURS framework for adding software to drug labels. Learn how it impacts pharma and what you need to know. Join us on Tuesday 9th July @ 07:00am PDT / 10:00am EDT / 15:00pm BST / 16:00pm CEST.
The webinar largely consisted of summarizing the general requirements under Parts 803, 806 and 820.198, which we do not reproduce here ( but see another of our prior blog posts discussing these requirements and their applicable to LDTs in greater detail; you can also find FDA’s slides from the webinar here ). By Steven J.
For PRISYM ID client RxSource , a Global Clinical Trial Supplies Specialist, it means being ready to partner with sponsor companies to get everything set up for a clinical trial within a week, including packaging and labeling. To find out more about the webinar and to register, visit [link] .
If there’s one take-home message about working during a pandemic, it is the enormous value that virtual events, webinars and e-learning can bring when face-to-face meetings and presentations are impossible. The main advantage of webinars and other online interactions is pretty obvious.
Conversion Rate: Tracks how many users complete a desired action, such as signing up for a webinar or downloading whitepapers. Avoiding misleading claims or unapproved off-label promotions. Offer incentives like exclusive research reports or webinar invites.
The development of software applications that are available with a prescription took a major step forward last year with the first FDA approval for a mobile medical application with both a safety and efficacy label. We’ll be looking at how digital and traditional approaches to medicine are being combined to improve patient outcomes.
We also highlight our members' perspectives on oral oncolytics, patient-centered prescription labels and food as medicine. Current medication labels often hinder safe and appropriate use of medicines. The next PQA Quality Essentials Webinar is Thursday, March 16, 1-2 pm ET.
Comment topics suggested by DEA include the following: Whether the rule should limit the issuance of prescriptions for controlled medications to FDA-approved indications contained in the labeling for those medications. We will release exciting details of our upcoming webinar addressing telemedicine soon. Stay tuned.
Webinars – Webinars, whether live streamed or on-demand, can be used for communication with HCPs, HCOs, and POs. A company is responsible for the content of webinars and should take reasonable steps to ensure the audience is targeted and well defined.
For example, we all know the importance of ensuring that syringes are labeled whenever medications are prepared but not immediately administered. 28 at 1 pm EST/10 am PST for the Omnicell Live webinar, “Medication Safety Perspectives: Best Practices in Hospital Pharmacies.”
In Apollo’s recent webinar , moderated by Glenna Crooks, Ph.D. Traditionally reliant on established methodologies, HEOR is now rapidly incorporating RWD and Real-World Evidence (RWE) to support label expansions and integrate with conventional research activities. For more context and a complete discussion, watch the webinar today.
Drug names and indications must align with FDA-approved labeling. signing up for a webinar, downloading a whitepaper)? FDA and Fair Balance Messaging All promotional emails must include fair balance messaging benefits and risks must be presented equally. No personal health information (PHI) can be used for targeting or personalization.
Omnicell XT cabinets support automated printing of a label with a machine-readable barcode to help nurses verify the right medication is being administered to the right patient. Watch this webinar to learn more about how automated dispensing systems support ISMP guidelines for medication safety.
In the years leading up to 2022, numerous publications were issued; networking events, webinars, and conferences were held; and regulatory panel discussions with regulators performed. and management communication strategy. ™ hackathons were established, and the ISPE Factory of the Year (FOYA) award category was created.
Labeling and Implant ID Card Lastly, it is critical that patients are provided with implant information as it pertains to their devices. separate patient labeling). Manufacturers should create user-friendly instructions for use that facilitate patient understanding of potential risks over the expected lifespan of the implant.
Join our next Awesome Webinar Series with guest legal guru JD from Real Value Rx to answer any questions you have about the DSCSA delay. Small Dispensers and the 6/12/2024 FDA Announcement Concerning DSCSA This week’s article on the recent DSCSA postponement comes from PRS Pharmacy Services. The original article can be found HERE.
I recently had the opportunity to attend the Sex & Gender 101 webinar designed to help anyone in the healthcare field learn more about creating trans inclusive care. The term nonbinary is a specific gender identity label and an umbrella term.
Under the proposed rule, any raw whole fruits and vegetables could be labeled healthy no matter the level of added sugars, sodium, or saturated fat. FDA also plans to host a stakeholder webinar on the final rule at a later date. The final rule does not limit this exemption to only raw fruits and vegetables.
Being aware of pharmaceutical advertising laws, fair balance requirements, and off-label promotion restrictions will prevent costly compliance mistakes. Combining HCP webinars, digital advertising, and interactive medical content enhances outreach effectiveness. Organizations like the FDA (U.S.),
LabelingLabeling Section VII Risk Assessment Risk Management File of Software Documentation Section VIII Data Management Data for development: Software Description of Software Documentation Data for testing: Performance Testing Section IX Model Description and Development Software Description Section X.A
While not terribly informative, under the prior administration, FDA held a webinar to outline the requirements of this Stage. The materials from this webinar are still available on FDAs website ( here ). Since the new administration took office, however, the webinar page has been taken down from FDAs website.
We organize all of the trending information in your field so you don't have to. Join 5,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content